Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors

Neuron

Volumn 19, Issue 4, 1997, Pages 837-848

  Xu, Ming ^a,e   Koeltzow, Timothy E ^b   Santiago, Giovanni Tirado ^c   Moratalla, Rosario ^d,f   Cooper, Donald C ^b   Hu, Xiu Ti ^b   White, Norman M ^c   Graybiel, Ann M ^d   White, Francis J ^b   Tonegawa, Susumu ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^e UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^f INSTITUTO CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

3,4,4A,10B TETRAHYDRO 4 PROPYL 2H,5H [1]BENZOPYRANO[4,3 B][1,4]OXAZIN 9 OL; 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; AMPHETAMINE; COCAINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR STIMULATING AGENT; PSYCHOSTIMULANT AGENT; QUINPIROLE; RESERPINE; SPIPERONE; TRITIUM;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CAUDATE NUCLEUS; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; GENE MUTATION; LIGAND BINDING; MOTOR ACTIVITY; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PUTAMEN; RECEPTOR BINDING; RECEPTOR GENE; VOLUNTARY MOVEMENT;

EID: 0030780877     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6273(00)80965-4     Document Type: Article

References (76)

1. 3 dopamine receptor gene is associated with hyperactivity in mice. Proc. Natl. Acad. Sci. USA 93, 1945-1949.
2. Baik, J., Picetti, R., Saiardi, A., Thiriet, G., Dierich, A., Depaulis, A., Le Meur, M., and Borrelli, E. (1995). Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature 377, 424-428.
3. Bechara, A., and van der Kooy, D. (1989).The tegmental pedunculopontine nucleus: a brain-stem output of the limbic system critical for the conditioned place preference produced by morphine and amphetamine. J. Neurosci. 9, 3400-3409.
4. Beninger, R.J. (1992). D-1 receptor involvement in reward-related learning. J. Psychopharmacol. 6, 34-42.
5. 2 receptor mRNA. Brain Res. 564, 203-219.
6. Bradley, A. (1987). Production and analysis of chimeric mice. In Teratocarcinomas and Embryonic Stem Cells: A Practical Approach, E.J. Robertson, ed. (Oxford: IRL Press), pp. 113-151.
7. 3 dopamine receptors. Neuropsychopharmacology 12, 335-345.
8. Cabib, S., Castellano, C., Cestari, V., Fillibeck, U., and Puglisi-Allegra, S. (1991). D1 and D2 receptor antagonists differently affect cocaine-induced locomotor hyperactivity in the mouse. Psychopharmacology 105, 335-339.
9. Caine, S.B., and Koob, G.F. (1993). Modulation of cocaine self-administration in the rat through D-3 dopamine receptors. Science 260, 1814-1816.
10. Calabresi, P., Saiardi, A., Pisani, A., Baik, J.H., Centonze, D., Mercuri, N.B., Bernardi, G., and Borrelli, E. (1997). Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors. J. Neurosci. 17, 4536-4544.
11. Carr, G.D., Phillips, A.G., and Fibiger, H.C. (1988). Independence of amphetamine reward from locomotor stimulation demonstrated by conditioned place preference. Psychopharmacology 94, 221-226.
12. Carr, G.D., Fibiger, H.C., and Phillips, A.G. (1989). Conditioned place preference as a measure of drug reward. In The Neuropharmacological Basis of Reward. J.M. Leibman and S.J. Cooper, eds. (Oxford: Oxford University Press), pp. 264-319.
13. Civelli, O., Bunzow, J.R., and Grandy, D.K. (1993). Molecular diversity of the dopamine receptors. Annu. Rev. Pharmacol. Toxicol. 33, 281-307.
14. 2 dopamine receptor classification and its functional implications. Synapse 1, 347-388.
15. Clark, D., Hjorth, S., and Carlsson, A. (1985). Dopamine-receptor agonists: mechanisms underlying autoreceptor selectivity: 1. review of the evidence. J. Neural Transm. 62, 1-52.
16. Daly, S.A., and Waddington, J.L. (1993). Behavioural effects of the putative D-3 dopamine receptor agonist 7-OH-DPAT in relation to other "D-2-like" agonists. Neuropharmacology 32, 509-510.
17. Dawson, G.R., and Tricklebank, M.D. (1995). Use of the elevated plus maze in the search for novel anxiolytic agents. Trends Pharmacol. Sci. 16, 33-36.
18. 3 receptor in the rat brain. Neuroscience 65, 731-745.
19. 1A dopamine receptors. Proc. Natl. Acad. Sci. USA 91, 12564-12568.
20. Everitt, B.J., Morris, K.A., O'Brien, A., and Robbins, T.W. (1991). The basolateral amygdala-ventral striatal system and conditioned place preference: further evidence of limbic-striatal interactions underlying reward-related processes. Neuroscience 42, 1-18.
21. Gingrich, J.A., and Caron, M.G. (1993). Recent advances in the molecular biology of dopamine receptors. Annu. Rev. Neurosci. 16, 299-321.
22. 3 receptors. Eur. J. Pharmacol. 272, R1-R3.
23. Graybiel, A.M. (1995). Building action repertoires: memory and learning functions of the basal ganglia. Curr. Opin. Neurol. 5, 733-741.
24. Graybiel, A.M., and Moratalla, R. (1989). Dopamine uptake sites in the striatum are distributed differentially in striosome and matrix compartments. Proc. Natl. Acad. Sci. USA 86, 9020-9024.
25. Hiroi, N., and White, N.M. (1991a). The amphetamine conditioned place preference: differential involvement of dopamine receptor subtypes and two dopaminergic terminal areas. Brain Res. 552, 141-152.
26. Hiroi, N., and White, N.M. (1991b). The lateral nucleus of the amygdala mediates expression of the amphetamine-produced conditioned place preference. J. Neurosci. 11, 2107-2116.
27. Hoebel, B.G., Monaco, A.P., Hernandez, L., Aulisi, E.F., Stanley, B.G., and Lenard, L.G. (1983). Self-injection of amphetamine directly into the brain. Psychopharmacology 81, 158-163.
28. Hu, X.-T., and Wang, R.Y. (1988). Comparison of effects of D1 and D2 dopamine receptor agonists on neurons in the rat caudate putamen: an electrophysiological study. J. Neurosci. 8, 4340-4348.
29. 2 receptor selective antagonists: electrophysiological and behavioral studies. Synapse 17, 43-61.
30. Hyman, S.E. (1996). Addiction to cocaine and amphetamine. Neuron 16, 901-904.
31. Jackson, D.M., and Hashizume, M. (1986). Bromocriptine induces marked locomotor stimulation in dopamine-depleted mice when D-1 dopamine receptors are stimulated with SKF 38393. Psychopharmacology 90, 147-149.
32. Jackson, D.M., Jenkins, O.F., and Ross, S.B. (1988). The motor effects of bromocriptine - a review. Psychopharmacology 95, 433-446.
33. Kelsey, J.E., Carlezon, Jr., W.A., and Falls, W.A. (1989). Lesions of the nucleus accumbens in rats reduce opiate reward but do not alter context-specific opiate tolerance. Behav. Neurosci. 103, 1327-1334.
34. Koob, G.F. (1996). Drug addiction: the Yin and Yang of hedonic homeostasis. Neuron 16, 893-896.
35. Landwehrmeyer, B., Mengod, G., and Palacios, J.M. (1993). Dopamine D3 receptor mRNA and binding sites in human brain. Mol. B rain Res. 18, 187-192.
36. 3 receptor: Chinese hamsters or Chinese whispers. Trends Pharmacol. Sci. 15, 46-47.
37. Laviola, G., Dell'Omo, G., Chiarotti, F., and Bignami, G. (1994). d-Amphetamine conditioned place preference in developing mice: relations with changes in activity and stereotypies. Behav. Neurosci. 108, 514-524.
38. Le Moal, M., and Simon, H. (1991). Mesocorticolimbic dopaminergic network: functional and regulatory roles. Physiol. Rev. 71, 1 55-234.
39. 2 dopamine receptors. Neuroscience 73, 131-143.
40. Lister, R.G. (1987). The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92, 180-185.
41. Mackey, W.B., and van der Kooy, D. (1985). Neuroleptics block the positive reinforcing effects of amphetamine but not of morphine as measured by place conditioning. Pharmacol. Biochem. Behav. 22, 101-105.
42. Markou, A., Weiss, F., Gold, L.H., Caine, S.B., Schulteis, G., and Koob, G. F. (1993). Animal models of drug craving. Psychopharmacology 112, 163-182.
43. Murray, A.M., Ryoo, H.L., Gurevich, E., and Joyce, J.N. (1994). Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain. Proc. Natl. Acad. Sci. USA 91, 11271-11275.
44. Olds, M.E. (1979). Hypothalamic substrate for the positive reinforcing properties of morphine in the rat. Brain Res. 168, 351-360.
45. Olds, M.E. (1982). Reinforcing effects of morphine in the nucleus accumbens. Brain Res. 237, 429-440.
46. Parsons, L.H., Caine, S.B., Sokoloff, P., Schwartz, J.C., Koob, G.F., and Weiss, F. (1996). Neurochemical evidence that postsynaptic nucleus accumbens D3 receptor stimulation enhances cocaine reinforcement. J. Neurochem. 67, 1078-1089.
47. Pickens, R., and Thompson, T. (1971). Characteristics of stimulant drug reinforcement. In Stimulus Properties of Drugs, T. Thompson and R. Pickens, eds. (New York: Appleton-Century-Crofts), pp. 172-192.
48. Reicher, M.A., and Holman, E.W. (1977). Location preference and flavor aversion reinforced by amphetamine in rats. Anim. Learn. Behav. 5, 343-346.
49. Robbins, T.W. (1992). Milestones in dopamine research. Semin. Neurosci. 4, 93-97.
50. 3 receptor antagonist, activates locomotion in rodents. J. Pharmacol. Exp. Ther. 275, 1239-1246.
51. Schechter, M.D., and Calcagnetti, D.J. (1993). Trends in place preference conditioning with a cross-indexed bibliography: 1957-1991. Neurosci. Biobehav. Rev. 17, 21-41.
52. Schotte, A., Janssen, P.F.M., Bonaventure, P., and Leysen, J.E. (1996). Endogenous dopamine limits the binding of antipsychotic drugs to D3 receptors in the rat brain: a quantitative autoradiographic study. Histochem. J. 28, 791-799.
53. Self, D.W., and Nestler, E.J. (1995). Molecular mechanisms of drug reinforcement and addiction. Annu. Rev. Neurosci. 18, 463-495.
54. Sokoloff, P., Giros, B., Martres, M.-P., Bouthenet, M.-L., and Schwartz, J.-C. (1990). Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 347, 146-151.
55. Surmeier, D.J., Eberwine, J., Wilson, C.J., Cao, Y., Stefani, A., and Kitai, S.T. (1992). Dopamine receptor subtypes colocalize in rat striatonigral neurons. Proc. Natl. Acad. Sci. USA 89, 10178-10182.
56. 3 receptors. Eur. J. Pharmacol. 263, 235-243.
57. 3 ligand R-(+)-7-OH-DPAT is independent of changes in dopamine release. J. Neural Transm. 95, 71-74.
58. Tella, S.R. (1994). Differential blockade of chronic versus acute effects of intravenous cocaine by dopamine receptor antagonists. Pharmacol. Biochem. Behav. 48, 151-159.
59. 2 Dopamine Receptor Interactions, J.L. Waddington, ed. (San Diego: Academic Press), pp. 51-78.
60. Walters, J.R., Bergstrom, D.A., Carlson, J.H., Chase, T.N., and Braun, A.R. (1987). D1 dopamine receptor activation required for postsynaptic expression of D2 agonist effects. Science 236, 719-722.
61. Waters, N., Svensson, K., Haadsma-Svennson, S.R., Smith, M.W., and Carlsson, A. (1993). The dopamine D3-receptor: a postsynaptic receptor inhibitory on rat locomotor activity. J. Neural Transm. 94, 11-19.
62. Waters, N., Löfberg, L., Haadsma-Svensson, S., Svensson, K., Sonesson, C., and Carlsson, A. (1994). Differential effects of dopamine D2 and D3 receptor antagonists in regard to dopamine release, in vivo receptor displacement and behaviour. J. Neural Transm. 98, 39-55.
63. White, N.M. (1989). A functional hypothesis concerning the striatal matrix and patches: mediation of S-R memory and reward. Life Sci. 45, 1943-1957.
64. White, N.M., and Carr, G.D. (1985). The conditioned place preference is affected by two independent reinforcement processes. Pharmacol. Biochem. Behav. 23, 37-42.
65. White, N.M., and Hiroi, N. (1993). Amphetamine conditioned cue preference and the neurobiology of drug seeking. Semin. Neurosci. 5, 329-336.
66. 2 Dopamine Receptor Interactions, J.L. Waddington, ed. (San Diego: Academic Press), pp. 79-114.
67. White, N.M., and Milner, P.M. (1992). The psychobiology of reinforcers. Annu. Rev. Psychol. 43, 443-471.
68. White, F.J., and Wang, R.Y. (1986). Electrophysiological evidence for the existence of both D-1 and D-2 dopamine receptors in the rat nucleus accumbens. J. Neurosci. 6, 274-280.
69. White, N.M., Messier, C., and Carr, G.D. (1987). Operationalizing and measuring the organizing influence of drugs on behavior. In Methods of Measuring the Reinforcing Properties of Abused Drugs, M.A. Bozarth, ed. (New York: Springer-Verlag), pp. 591-618.
70. White, F.J., Bednarz, L.M., Wachtel, S.R., Hjorth, S., and Brooderson, R.J. (1988). Is stimulation of both D1 and D2 receptors necessary for the expression of dopamine-mediated behaviors? Pharmacol. Biochem. Behav. 30, 189-193.
71. White, N.M., Packard, M.G., and Hiroi, N. (1991). Place conditioning with dopamine D1 and D2 agonists injected peripherally or into nucleus accumbens. Psychopharmacology 103, 271-276.
72. White, F.J., Hu, X.-T., and Henry, D.J. (1993). Electrophysiological effects of cocaine in the rat nucleus accumbens: microiontophoretic studies. J. Pharmacol. Exp. Ther. 266, 1075-1084.
73. Xu, M., Moratalla, R., Gold, L.H., Hiroi, N., Koob, G.F., Graybiel, A.M., and Tonegawa, S. (1994a). Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell 79, 729-742.
74. Xu, M., Hu, X.T., Cooper, D.C., Moratalla, R., Graybiel, A.M., White, F.J., and Tonegawa, S. (1994b). Elimination of cocaine-induced hyperactivity and dopamine-mediated neurophysiological effects in dopamine D1 receptor mutant mice. Cell 79, 945-955.
75. Xu, M., Hu, X.T., Cooper, D.C., White, F.J., and Tonegawa, S. (1996). A genetic approach to study mechanisms of cocaine action. Ann. N.Y. Acad. Sci. 801, 51-63.
76. Zahm, D.S., and Brog, J.S. (1992). On the significance of subterritories in the "accumbens" part of the rat ventral striatum. Neuroscience 50, 751-767.